SCHEMBL31679441

SCHEMBL31679441

CCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CS)[C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ NTSR1 P30989 2/20 0.51
▸ NTSR2 O95665 1/20 0.51
▸ KEAP1 Q14145 2/20 0.50
▸ OPRD1 P41143 6/20 0.49
▸ IL23R Q5VWK5 1/20 0.47
▸ MAPK8 P45983 1/20 0.47
▸ MAPK9 P45984 1/20 0.47
▸ MAPK10 P53779 1/20 0.47
▸ OPRM1 P35372 1/20 0.46
▸ OPRK1 P41145 1/20 0.46
▸ VIPR2 P41587 3/20 0.46
▸ VIPR1 P32241 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31679415 0.96 MAPK8 (0.47) NTSR1NTSR2KEAP1OPRD1MAPK8
SCHEMBL31679412 0.94 MAPK8 (0.50) NTSR1NTSR2KEAP1OPRD1MAPK8
SCHEMBL31679452 0.92 F2 (0.49) NTSR1NTSR2KEAP1OPRD1MAPK8
SCHEMBL31679423 0.91 AGTR2 (0.51) NTSR1NTSR2OPRD1IL23RMAPK8
SCHEMBL31679418 0.91 OPRD1 (0.54) NTSR1NTSR2OPRD1MAPK8MAPK9
SCHEMBL31679366 0.90 MAPK8 (0.50) OPRD1IL23RMAPK8MAPK9MAPK10
SCHEMBL31679451 0.89 AGTR2 (0.52) NTSR1NTSR2OPRD1MAPK8MAPK9
SCHEMBL31679462 0.89 AGTR2 (0.52) NTSR1NTSR2OPRD1IL23RMAPK8
SCHEMBL31679409 0.88 OPRD1 (0.49) NTSR1NTSR2KEAP1OPRD1MAPK8
SCHEMBL31679349 0.88 OPRD1 (0.51) KEAP1OPRD1IL23ROPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4610269-A1 UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR (UPAR) LIGANDS FOR DIAGNOSTIC OR THERAPEUTIC USE 3B Pharmaceuticals GmbH (DE) 2025-09-03 — — EP disclosed
Send feedback